NM_001031689.3:c.150-5519G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001031689.3(PLAA):c.150-5519G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 152,088 control chromosomes in the GnomAD database, including 1,108 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1108 hom., cov: 32)
Consequence
PLAA
NM_001031689.3 intron
NM_001031689.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.423
Publications
3 publications found
Genes affected
PLAA (HGNC:9043): (phospholipase A2 activating protein) Predicted to enable ubiquitin binding activity. Involved in cellular response to lipopolysaccharide; macroautophagy; and positive regulation of phospholipase A2 activity. Located in cytoplasm; extracellular exosome; and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
PLAA Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomaliesInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PLAA | ENST00000397292.8 | c.150-5519G>A | intron_variant | Intron 1 of 13 | 1 | NM_001031689.3 | ENSP00000380460.3 | |||
| PLAA | ENST00000520884.5 | c.150-5519G>A | intron_variant | Intron 1 of 12 | 2 | ENSP00000429372.1 | ||||
| PLAA | ENST00000523212.1 | c.87-5528G>A | intron_variant | Intron 1 of 5 | 3 | ENSP00000428111.1 |
Frequencies
GnomAD3 genomes AF: 0.114 AC: 17378AN: 151970Hom.: 1104 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
17378
AN:
151970
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.114 AC: 17410AN: 152088Hom.: 1108 Cov.: 32 AF XY: 0.112 AC XY: 8347AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
17410
AN:
152088
Hom.:
Cov.:
32
AF XY:
AC XY:
8347
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
7301
AN:
41476
American (AMR)
AF:
AC:
1355
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
456
AN:
3472
East Asian (EAS)
AF:
AC:
138
AN:
5174
South Asian (SAS)
AF:
AC:
557
AN:
4820
European-Finnish (FIN)
AF:
AC:
803
AN:
10564
Middle Eastern (MID)
AF:
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6392
AN:
67970
Other (OTH)
AF:
AC:
249
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
770
1540
2311
3081
3851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
324
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.